Literature DB >> 8770108

Phosphatidic acid increases intracellular free Ca2+ and cardiac contractile force.

Y J Xu1, V Panagia, Q Shao, X Wang, N S Dhalla.   

Abstract

Although phosphatidic acid (PA) is mainly formed due to the hydrolysis of phosphatidylcholine by myocardial phospholipase D, its functional significance in the heart is not fully understood. The present study was designed to determine the effects of PA on intracellular free Ca2+ level ([Ca2+]i) in freshly isolated adult rat cardiomyocytes by using fura 2-acextoxmethylester and free fura 2 technique. Addition of PA at concentrations of 1-200 microM produced a concentration-dependent increase in [Ca2+]i from the basal level of 117 +/- 8 nM; maximal increase in [Ca2+]i was 233 +/- 50 nM, whereas median effective concentration (EC50) for PA was 45 +/- 1.2 microM. This increase in [Ca2+]i was abolished by the removal of extracellular Ca2+ with ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid and was partially attenuated by Ca2+ channel blockers, verapamil or diltiazem. Preincubation of cardiomyocytes with cyclopiazonic acid and thapsigargin or with ryanodine [to deplete sarcoplasmic reticulum (SR) Ca2+] attenuated the PA-induced increase in [Ca2+]i by 66, 37, and 43%, respectively. Furthermore, the response of [Ca2+]i to PA was blunted by 2-nitro-4 carboxyphenylcarbonate, an inhibitor of phospholipase C, but was unaffected by staurosporine, a protein kinase C inhibitor. PA was also observed to induce Ca2+ efflux from the myocytes. In addition, an injection of PA (0.34 microgram/100 g body wt i.v.) in rats produced a significant increase of the left ventricular developed pressure as well as the maximum rates of cardiac contraction and relaxation within 5 min. These data suggest that the PA-induced increase in [Ca2+]i in cardiomyocytes is a consequence of both Ca2+ influx from the extracellular source and Ca2+ release from the intracellular SR stores. Furthermore, these in vitro data suggest the possibility that PA may regulate [Ca2+]i and contractile parameters in the heart.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8770108     DOI: 10.1152/ajpheart.1996.271.2.H651

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Abnormalities in sarcolemmal phospholipase D and phospholipase C isoenzymes and in their interactions in post-infarcted failing hearts.

Authors:  V Panagia; P S Tappia; C Yu; N Takeda; N S Dhalla
Journal:  Lipids       Date:  1999       Impact factor: 1.880

2.  Fura-2 fluorescent technique for the assessment of Ca2+ homeostasis in cardiomyocytes.

Authors:  Y J Xu; Q Shao; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

3.  Kinetics of myocardial phospholipase D.

Authors:  J Dai; S Y Liu; V Panagia
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

4.  Mechanisms of low Na(+)-induced increase in intracellular calcium in KCl-depolarized rat cardiomyocytes.

Authors:  Satyajeet S Rathi; Harjot K Saini; Yan-Jun Xu; Naranjan S Dhalla
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

5.  Phosphatidic acid mediates activation of mTORC1 through the ERK signaling pathway.

Authors:  Jeremiah N Winter; Todd E Fox; Mark Kester; Leonard S Jefferson; Scot R Kimball
Journal:  Am J Physiol Cell Physiol       Date:  2010-04-28       Impact factor: 4.249

6.  Differential Aortic and Mitral Valve Interstitial Cell Mineralization and the Induction of Mineralization by Lysophosphatidylcholine In Vitro.

Authors:  Dena C Wiltz; Richard I Han; Reid L Wilson; Aditya Kumar; Joel D Morrisett; K Jane Grande-Allen
Journal:  Cardiovasc Eng Technol       Date:  2014-12-01       Impact factor: 2.495

7.  Mechanism of cardioprotective action of TNF-alpha in the isolated rat heart.

Authors:  Satyajeet S Rathi; Yan-Jun Xu; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2002

Review 8.  Anthracycline-induced phospholipase A2 inhibition.

Authors:  Luther Swift; Jane McHowat; Narine Sarvazyan
Journal:  Cardiovasc Toxicol       Date:  2007       Impact factor: 3.231

9.  Defective sarcolemmal phospholipase C signaling in diabetic cardiomyopathy.

Authors:  Paramjit S Tappia; Girma Asemu; Nina Aroutiounova; Naranjan S Dhalla
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

Review 10.  Mammalian phospholipase D: Function, and therapeutics.

Authors:  M I McDermott; Y Wang; M J O Wakelam; V A Bankaitis
Journal:  Prog Lipid Res       Date:  2019-12-09       Impact factor: 16.195

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.